The impact of the AIDS drug assistance program (ADAP) on use of highly active antiretroviral and antihypertensive therapy among HIV-infected women

Journal of Acquired Immune Deficiency Syndromes

Volumn 56, Issue 3, 2011, Pages 253-262

  Yi, Thomas ^a   Cocohoba, Jennifer ^a   Cohen, Mardge ^b   Anastos, Kathryn ^c   Dehovitz, Jack A ^d   Kono, Naoko ^e   Hanna, David B ^f   Hessol, Nancy A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Jr Hospital of Cook County   (United States)

^c MONTEFIORE MEDICAL CENTER   (United States)

^d SUNY DOWNSTATE MEDICAL CENTER   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

AIDS; antiretroviral therapy; healthcare disparity; hypertension; prescription insurance; women

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTIVIRUS AGENT;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BEHAVIOR; CROSS-SECTIONAL STUDY; DEMOGRAPHY; FEMALE; GOVERNMENT; HEALTH SERVICE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; MAJOR CLINICAL STUDY; PRESCRIPTION; PRIORITY JOURNAL; UNITED STATES;

ADULT; ANTI-HIV AGENTS; ANTIHYPERTENSIVE AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CALIFORNIA; FEMALE; HIV INFECTIONS; HUMANS; HYPERTENSION; ILLINOIS; MEDICATION ADHERENCE; MIDDLE AGED; NEW YORK;

EID: 79951811535     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31820a9d04     Document Type: Article

References (28)

1. National ADAP Monitoring Project Annual Report. The Henry J. Kaiser Family Foundation web site. Available at: www.kff.org/hivaids/ upload/7861.pdf. April 2009. Accessed May 5, 2009.
2. DHHS Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. AIDSinfo. Available at: http://aidsinfo.nih.gov/ contentfiles/AdultandAdolescentGL.pdf. December 1, 2009. Accessed March 8, 2010.
3. Gazzaruso C, Bruno R, Garzaniti A, et al. Hypertension among HIV patients: prevalence and relationships to insulin resistance and metabolic syndrome. J Hypertens. 2003;21:1377-1382.
4. Jung O, Bickel M, Ditting T, et al. Hypertension in HIV-1-infected patients and its impact on renal and cardiovascular integrity. Nephrol Dial Transplant. 2004;19:2250-2258. (Pubitemid 39214118)
5. Andersen R, Bozzette S, Shapiro M, et al. Access of vulnerable groups to antiretroviral therapy among persons in care for HIV disease in the United States. Health Serv Res. 2000;35:389-416. (Pubitemid 30396962)
6. Baillargeon J, Giordano, TP, Rich JD, et al. Accessing antiretroviral therapy following release from prison. JAMA. 2009;301: 848-857.
7. Keruly JC, Conviser R, Moore RD. Association of medical insurance and other factors with receipt of antiretroviral therapy. Am J Public Health. 2002;92:852-857. (Pubitemid 34441643)
8. King WD, Minor P, Ramirez Kitchen C, et al. Racial, gender and geographic disparities of antiretroviral treatment among US Medicaid enrollees in 1998. J Epidemiol Community Health. 2008;62: 798-803.
9. Gebo KA, Fleishman JA, Conviser R, et al. Racial and gender disparities in receipt of highly active antiretroviral therapy persist in a multistate sample of HIV patients in 2001. J Acquir Immune Defic Syndr. 2005;38: 96-103. (Pubitemid 40094126)
10. Cook JA, Cohen MH, Grey D, et al. Use of highly active antiretroviral therapy in a cohort of HIV-seropositivewomen. Am J Public Health. 2002; 92:82-87. (Pubitemid 36018895)
11. Lillie-Blanton M, Stone VE, Snow Jones A, et al. Association of race, substance abuse, and health insurance coverage with use of highly active antiretroviral therapy among HIV-infected women, 2005. Am J Public Health. 2010;100:1493-1499.
12. Cohen MH, Cook JA, Grey DD, et al. Medically eligible women who do not use HAART: the importance of abuse, drug use, and race. Am J Public Health. 2004;94:1147-1151. (Pubitemid 38857315)
13. Cook JA, Cohen MH, Grey D, et al. Use of highly active antiretroviral therapy in a cohort of HIV-seropositivewomen. Am J Public Health. 2002; 92:82-87. (Pubitemid 36018895)
14. Cunningham WE, Markson LE, Andersen RM, et al. Prevalence and predictors of highly active antiretroviral therapy use in patients with HIV infection in the United States. J Acquir Immune Defic Syndr. 2000;25: 115-123.
15. Barkan SE, Melnick SL, Preston-Martin S, et al. The Women's Interagency HIV Study. WIHS Collaborative Study Group. Epidemiology. 1998;9:117-125. (Pubitemid 28157608)
16. Bacon MC, von Wyl V, Alden C, et al. The Women's Interagency HIV Study: an observational cohort brings clinical sciences to the bench. Clin Diagn Lab Immunol. 2005;19:1013-1019. (Pubitemid 41324530)
17. DHHS Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. AIDSinfo. Available at: http://aidsinfo.nih.gov/ contentfiles/AdultandAdolescentGL000988.pdf. January 9, 2008. Accessed March 8, 2010.
18. Centers for Disease Control and Prevention. 1993 Revised Classification System for HIV Infection and Expanded Surveillance Case Definition for AIDS Among Adolescents and Adults. Morbidity and Mortality Weekly Report. Available at: www.cdc.gov/mmwr/preview/mmwrhtml/ 00018871.htm. December 18, 1992. Accessed April 4, 2010.
19. US Department of Health and Human Services. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JNC 7 Full Report. Available at: www.nhlbi.nih.gov/ guidelines/hypertension/jnc7full.pdf. August 2004. Accessed March 8, 2010.
20. Bozzette SA, Hays RD, Berry SH, et al. Derivation and properties of a brief health status assessment instrument for use in HIV disease. J Acquir Immune Defic Syndr. 1995;8:253-265.
21. SASInstitute Inc. SAS/STAT User's Guide, Version 9.2. 2008.
22. Oparil S. Women and hypertension: what did we learn from the Women's Health Initiative? Cardiol Rev. 2006;14:267-275. (Pubitemid 44624585)
23. Ockene IS, Miller NH. Cigarette smoking, cardiovascular disease, and stroke. A statement for healthcare professionals from the American Heart Association. Circulation. 1997;96:3243-3247. (Pubitemid 27500133)
24. Lavigne M, Rocher I, Steensma C, et al. The impact of smoking on adherence to treatment for latent tuberculosis infection. BMC Public Health. 2006;6:66.
25. Giles T, Aranda JM, Suh DC, et al. Ethnic/racial variations in blood pressure awareness, treatment, and control. J Clin Hypertens. 2007:345-354.
26. Gu Q, Burt VL, Paulrose-Ram R, et al. Gender differences in hypertension treatment, drug utilization patterns, and blood pressure control among US adults with hypertension: data from the National Health and Nutrition Examination Survey 1999-2004. Am J Hypertens. 2008;21:789-798. (Pubitemid 351913621)
27. Hertz RP, Unger AN, Cornell JA, et al. Racial disparities in hypertension prevalence, awareness, and management. Arch Intern Med. 2005;165: 2098-2104. (Pubitemid 41434584)
28. Cargill VA, Stone VE. HIV/AIDS: a minority health issue. Med Clin North Am. 2005;89:895-912. (Pubitemid 40755549)